New combo therapy shows promise for Hard-to-Treat melanoma
NCT ID NCT04640545
First seen Sep 30, 2025 · Last updated May 16, 2026 · Updated 31 times
Summary
This early-phase study tested a new drug called LBL-007 combined with toripalimab (and sometimes axitinib) in 79 people with advanced melanoma that could not be removed by surgery or had spread. The main goals were to check safety, find the best dose, and see if tumors shrink. Participants had to be at least 18, in good general health, and have measurable tumors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Cancer Hospital
Beijing, Beijing Municipality, 100142, China
-
Fujian Cancer Hospital
Fuzhou, Fujian, 350000, China
-
Hunan Cancer Hospital
Changsha, Hunan, 410006, China
-
Jilin Cancer Hospital
Changchun, Jilin, 130021, China
-
Nanjing Drum Tower Hospital
Nanjing, Jiangsu, 210008, China
-
Union Hospital Tongji Medical College Huazhong University of Science and Technology
Wuhan, Hubei, 430022, China
-
West China Hospital of Sichuan University
Chengdu, Sichuan, 610041, China
Conditions
Explore the condition pages connected to this study.